title: Alterations of calcium channels and cell excitability in intracardiac ganglion neurons from type 2 diabetic rats.
abstract: Clinical study has demonstrated that patients with type 2 diabetes with attenuated arterial baroreflex have higher mortality rate compared with those without arterial baroreflex dysfunction. As a final pathway for the neural control of the cardiac function, functional changes of intracardiac ganglion (ICG) neurons might be involved in the attenuated arterial baroreflex in the type 2 diabetes mellitus (T2DM). Therefore, we measured the ICG neuron excitability and Ca(2+) channels in the sham and T2DM rats. T2DM was induced by a combination of both high-fat diet and low-dose streptozotocin (STZ, 30 mg/kg ip) injection. After 12-14 wk of the above treatment, the T2DM rats presented hyperglycemia, hyperlipidemia, and insulin resistance but no hyperinsulinemia, which closely mimicked the clinical features of the patients with T2DM. Data from immunofluorescence staining showed that L, N, P/Q, and R types of Ca(2+) channels were expressed in the ICG neurons, but only protein expression of N-type Ca(2+) channels was decreased in the ICG neurons from T2DM rats. Using whole cell patch-clamp technique, we found that T2DM significantly reduced the Ca(2+) currents and cell excitability in the ICG neurons. ω-Conotoxin GVIA (a specific N-type Ca(2+) channel blocker, 1 μM) lowered the Ca(2+) currents and cell excitability toward the same level in sham and T2DM rats. These results indicate that the decreased N-type Ca(2+) channels contribute to the suppressed ICG neuron excitability in T2DM rats. From this study, we think high-fat diet/STZ injection-induced T2DM might be an appropriate animal model to test the cellular and molecular mechanisms of cardiovascular autonomic dysfunction.
authors.affiliation: Department of Emergency Medicine, University of Nebraska Medical Center, Omaha, 68198-5850, USA.
authors.forename: Jinxu
authors.initials: J
authors.lastname: Liu
authors.forename: Huiyin
authors.initials: H
authors.lastname: Tu
authors.forename: Hong
authors.initials: H
authors.lastname: Zheng
authors.forename: Libin
authors.initials: L
authors.lastname: Zhang
authors.forename: Thai P
authors.initials: TP
authors.lastname: Tran
authors.forename: Robert L
authors.initials: RL
authors.lastname: Muelleman
authors.forename: Yu-Long
authors.initials: YL
authors.lastname: Li
mesh_terms: D000818:Animals; D001158:Arteries / Q000378:metabolism / Q000503:physiopathology; D017704:Baroreflex / Q000235:genetics / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D059305:Diet, High-Fat; D005724:Ganglia / Q000378:metabolism* / Q000473:pathology; D006321:Heart / Q000503:physiopathology; D008297:Male; D009474:Neurons / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D020866:omega-Conotoxin GVIA / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D012333:RNA, Messenger; D020866:omega-Conotoxin GVIA; D002118:Calcium